The Effect of Rectus Sheath Block on the Postoperative Analgesia in the Patients Undergoing Robotic Single Port Cholecystectomy

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02827097

Enrollment

Registered

2016-07-11

Start date

2016-10-31

Completion date

2016-10-31

Last updated

2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Diseases

Brief summary

The primary purpose of this study is to investigate the effect of rectus sheath block on abdominal pain score after robotic single port cholecystectomy. The secondary purpose of this study is to investigate the effect of rectus sheath block on fentanyl consumption during stay of recovery room after surgery.

Interventions

DRUGdenogan and rectus sheath block

administration of denogan and rectus sheath block with 0.375% ropivacaine

DRUGdenogan

administration of denogan

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* robotic single Port cholecystectomy for gallbladder disease

Exclusion criteria

* Allergy to ropivacaine, infection, history of abdominal surgery, body mass index more than 30

Design outcomes

Primary

Measure	Time frame
Abdominal pain score after surgery	Change from baseline abdominal pain score up to 24 hours

Secondary

Measure	Time frame
Fentanyl consumption in recovery room	Up to 1 hours

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026